Sectra Valuation
Is SECTBS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SECTBS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SECTBS (SEK269) is trading above our estimate of fair value (SEK12.17)
Significantly Below Fair Value: SECTBS is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SECTBS?
Other financial metrics that can be useful for relative valuation.
What is SECTBS's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | SEK 51.52b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 16x |
Enterprise Value/EBITDA | 85.9x |
PEG Ratio | 5.4x |
Price to Earnings Ratio vs Peers
How does SECTBS's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 51.1x | ||
CRW Craneware | 82.2x | 25.6% | UK£717.0m |
EMIS EMIS Group | 40.4x | 11.0% | UK£1.2b |
INS Instem | 59.8x | n/a | UK£199.6m |
MDC Mediclinic International | 21.9x | 10.7% | UK£3.7b |
SECTBS Sectra | 115.2x | 21.2% | SEK 51.5b |
Price-To-Earnings vs Peers: SECTBS is expensive based on its Price-To-Earnings Ratio (115.2x) compared to the peer average (82.2x).
Price to Earnings Ratio vs Industry
How does SECTBS's PE Ratio compare vs other companies in the European Healthcare Services Industry?
Price-To-Earnings vs Industry: SECTBS is expensive based on its Price-To-Earnings Ratio (115.2x) compared to the European Healthcare Services industry average (18.9x).
Price to Earnings Ratio vs Fair Ratio
What is SECTBS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 115.2x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SECTBS's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | SEK 177.50 0% | 35.2% | SEK 240.00 | SEK 115.00 | n/a | 2 |
Sep ’25 | n/a | SEK 167.50 0% | 31.3% | SEK 220.00 | SEK 115.00 | n/a | 2 |
Aug ’25 | n/a | SEK 167.50 0% | 31.3% | SEK 220.00 | SEK 115.00 | n/a | 2 |
Jul ’25 | SEK 246.70 | SEK 167.50 -32.1% | 31.3% | SEK 220.00 | SEK 115.00 | n/a | 2 |
Jun ’25 | n/a | SEK 150.00 0% | 23.3% | SEK 185.00 | SEK 115.00 | n/a | 2 |
May ’25 | SEK 216.70 | SEK 150.00 -30.8% | 23.3% | SEK 185.00 | SEK 115.00 | n/a | 2 |
Apr ’25 | n/a | SEK 150.00 0% | 23.3% | SEK 185.00 | SEK 115.00 | n/a | 2 |
Mar ’25 | SEK 209.03 | SEK 142.50 -31.8% | 19.3% | SEK 170.00 | SEK 115.00 | n/a | 2 |
Feb ’25 | n/a | SEK 142.50 0% | 19.3% | SEK 170.00 | SEK 115.00 | n/a | 2 |
Jan ’25 | SEK 181.28 | SEK 127.50 -29.7% | 9.8% | SEK 140.00 | SEK 115.00 | n/a | 2 |
Dec ’24 | SEK 139.11 | SEK 132.50 -4.8% | 5.7% | SEK 140.00 | SEK 125.00 | n/a | 2 |
Nov ’24 | n/a | SEK 132.50 0% | 5.7% | SEK 140.00 | SEK 125.00 | n/a | 2 |
Oct ’24 | n/a | SEK 132.50 0% | 5.7% | SEK 140.00 | SEK 125.00 | n/a | 2 |
Sep ’24 | n/a | SEK 132.50 0% | 5.7% | SEK 140.00 | SEK 125.00 | n/a | 2 |
Aug ’24 | n/a | SEK 132.50 0% | 5.7% | SEK 140.00 | SEK 125.00 | n/a | 2 |
Jul ’24 | SEK 178.90 | SEK 127.50 -28.7% | 2.0% | SEK 130.00 | SEK 125.00 | SEK 246.70 | 2 |
Jun ’24 | SEK 178.80 | SEK 127.50 -28.7% | 2.0% | SEK 130.00 | SEK 125.00 | n/a | 2 |
May ’24 | n/a | SEK 127.50 0% | 2.0% | SEK 130.00 | SEK 125.00 | SEK 216.70 | 2 |
Apr ’24 | SEK 160.18 | SEK 127.50 -20.4% | 2.0% | SEK 130.00 | SEK 125.00 | n/a | 2 |
Analyst Forecast: Target price is lower than the current share price.